- This event has passed.
PBSS Online Symposium: Preclinical Models to Guide Therapeutic Development in Oncology – Day 1
December 8, 2020
Speakers: Mark Merchant (Genentech), Maryland Franklin (Covance Preclinical Oncology), Karen Rex (Amgen), Willem Overwijk (Nektar Therapeutics), Shelley Ackerman (Bolt Biotherapeutics)
Organizers: Gregory Wagner and Betty Chang
Date: 2020-12-08
Time: 8:45-13:00 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2020-12-07 (it will close sooner if the seating cap is reached)
About the Topic
Day 1: December 08, 2020 – In Vivo Models and Case Studies with Targeted Therapeutics
- Symposium Overview and Relevance to Contemporary Issues in Development of Therapeutic Agents for Oncology (Mark Merchant, Genentech)
- Preclinical Mouse Models for Oncology and Immuno-oncology Applications (Maryland Franklin, Covance-Preclinical Oncology)
- Preclinical Development of AMG 510, a First-in-human Covalent Inhibitor of KRASG12C for the Treatment of Advanced Solid Tumors (Karen Rex, Amgen)
- Preclinical Investigation of NKTR-255, a Polymer Conjugated IL-15 with Potent NK cell Activation and anti-tumor activity in combination with tumor targeting antibodies (Willem Overwijk, Nektar Therapeutics)
- Case Study: Bench to Bedside with Immune Stimulating Antibody Conjugates (ISAC) (Shelley Ackerman, Bolt Biotherapeutics)
